Shuoqiu Deng
Researcher
Also affiliated: Arkansas Children's Hospital (2026); Nanjing University of Chinese Medicine (2019); Chinese Academy of Medical Sciences & Peking Union Medical College (2020–2026); University of Arkansas Medical Center (2025); China Academy of Chinese Medical Sciences (2020–2025); Arkansas Children's Nutrition Center (2026)
Faculty Researcher
Research Areas
Biomedical Subjects
Links
Biography and Research Information
OverviewAI-generated summary
Shuoqiu Deng's research investigates the pharmacological effects of traditional Chinese medicine and specific compounds on cardiovascular and neurological conditions. Deng has published work on the protective mechanisms of Shengmai formula and Shenlian extract against myocardial injury induced by particulate matter and ischemia, often involving pathways such as PI3K/AKT/p38 MAPK/Nrf2 and NLRP3 inflammasomes. Other research areas include the effects of artesunate and tetramethylpyrazine on experimental cerebral malaria and ischemic stroke, focusing on mechanisms like protein S-nitrosylation and blood-brain barrier preservation. Deng also explores pharmacotherapeutic strategies for particulate matter-induced lung and cardiovascular damage and has reviewed cardiovascular complications in malaria. Collaborations include work with Christoph Mora, Yunmeng Liu, Katherine Deck, and Pamela I. Rogers at the University of Arkansas for Medical Sciences.
Metrics
- h-index: 5
- Publications: 33
- Citations: 98
Selected Publications
-
Macrophage Plasticity Drives Cardiac Dysfunction in Hypertension 2253031 (2026)
-
Antigen-independent formation of renal Trm-like CD8 T cells perpetuates hypertension 2259853 (2026)
-
Kidney Resident Memory CD8+ T cells drive the immortality of hypertension (2026)
-
Cytokine-mediated macrophage transition promotes early cardiac fibrosis in chronic hypertension (2026)
-
IL-10 Drives Macrophage to Myofibroblast Transition Promoting Chronic Fibrosis in the Failing Heart 9287 (2025)
-
P2X7 Drives T-cell Activation Promoting Chronic Inflammation During High Blood Pressure 9289 (2025)
-
Kidney resident-memory CD8+ T cells drive chronic high blood pressure 9288 (2025)
-
Energy Overload: ATP-P2X7-Mediated T Cell Activation in Obesity-Induced Type 2 Diabetes 9286 (2025)
-
Kidney Memory for Salt Sensitivity Resides in T Cells Driving Chronic Hypertension (2025)
-
Uncovering immune pathways for therapeutic targeting of hypertension (2025)
-
Immune Dysregulation Connecting Type 2 Diabetes and Cardiovascular Complications (2025)
-
Cytokine-induced Macrophage Transition Drives Cardiac Fibrosis and Diastolic Dysfunction (2025)
-
Establishment of resident memory T cells anchors hypertension in the kidney (2025)
-
SS-31 Attenuates Doxorubicin-induced Cardiomyoblast H9C2 Cell Senescence (2024)
Collaboration Network
Top Collaborators
- SS-31 Attenuates Doxorubicin-induced Cardiomyoblast H9C2 Cell Senescence
- Establishment of resident memory T cells anchors hypertension in the kidney
- Cytokine-induced Macrophage Transition Drives Cardiac Fibrosis and Diastolic Dysfunction
- Immune Dysregulation Connecting Type 2 Diabetes and Cardiovascular Complications
- Uncovering immune pathways for therapeutic targeting of hypertension
Showing 5 of 9 shared publications
- Establishment of resident memory T cells anchors hypertension in the kidney
- Cytokine-induced Macrophage Transition Drives Cardiac Fibrosis and Diastolic Dysfunction
- Immune Dysregulation Connecting Type 2 Diabetes and Cardiovascular Complications
- Uncovering immune pathways for therapeutic targeting of hypertension
- Kidney Memory for Salt Sensitivity Resides in T Cells Driving Chronic Hypertension
Showing 5 of 8 shared publications
- Establishment of resident memory T cells anchors hypertension in the kidney
- Cytokine-induced Macrophage Transition Drives Cardiac Fibrosis and Diastolic Dysfunction
- Immune Dysregulation Connecting Type 2 Diabetes and Cardiovascular Complications
- Uncovering immune pathways for therapeutic targeting of hypertension
- Kidney Memory for Salt Sensitivity Resides in T Cells Driving Chronic Hypertension
Showing 5 of 8 shared publications
- Establishment of resident memory T cells anchors hypertension in the kidney
- Cytokine-induced Macrophage Transition Drives Cardiac Fibrosis and Diastolic Dysfunction
- Immune Dysregulation Connecting Type 2 Diabetes and Cardiovascular Complications
- Uncovering immune pathways for therapeutic targeting of hypertension
- Kidney Memory for Salt Sensitivity Resides in T Cells Driving Chronic Hypertension
Showing 5 of 8 shared publications
- Establishment of resident memory T cells anchors hypertension in the kidney
- Cytokine-induced Macrophage Transition Drives Cardiac Fibrosis and Diastolic Dysfunction
- Immune Dysregulation Connecting Type 2 Diabetes and Cardiovascular Complications
- Uncovering immune pathways for therapeutic targeting of hypertension
- Kidney resident-memory CD8+ T cells drive chronic high blood pressure 9288
Showing 5 of 6 shared publications
- Cytokine-induced Macrophage Transition Drives Cardiac Fibrosis and Diastolic Dysfunction
- Kidney Memory for Salt Sensitivity Resides in T Cells Driving Chronic Hypertension
- Energy Overload: ATP-P2X7-Mediated T Cell Activation in Obesity-Induced Type 2 Diabetes 9286
- Kidney resident-memory CD8+ T cells drive chronic high blood pressure 9288
- IL-10 Drives Macrophage to Myofibroblast Transition Promoting Chronic Fibrosis in the Failing Heart 9287
- Establishment of resident memory T cells anchors hypertension in the kidney
- Immune Dysregulation Connecting Type 2 Diabetes and Cardiovascular Complications
- Uncovering immune pathways for therapeutic targeting of hypertension
- Immune Dysregulation Connecting Type 2 Diabetes and Cardiovascular Complications
- Uncovering immune pathways for therapeutic targeting of hypertension
- Kidney Memory for Salt Sensitivity Resides in T Cells Driving Chronic Hypertension
- Energy Overload: ATP-P2X7-Mediated T Cell Activation in Obesity-Induced Type 2 Diabetes 9286
- SS-31 Attenuates Doxorubicin-induced Cardiomyoblast H9C2 Cell Senescence
- SS-31 Attenuates Doxorubicin-induced Cardiomyoblast H9C2 Cell Senescence
- SS-31 Attenuates Doxorubicin-induced Cardiomyoblast H9C2 Cell Senescence
- SS-31 Attenuates Doxorubicin-induced Cardiomyoblast H9C2 Cell Senescence
- SS-31 Attenuates Doxorubicin-induced Cardiomyoblast H9C2 Cell Senescence
- SS-31 Attenuates Doxorubicin-induced Cardiomyoblast H9C2 Cell Senescence
Similar Researchers
Based on overlapping research topics